Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Cyprus, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Cyprus data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €178.3k | €207.6k | €233.8k | |||
| Patients | 292 | 340 | 383 |
Forecasts to 2030 — sales, patients and the full Cyprus series — are in the Cyprus data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
in-cyprus.philenews.com · №424 · 31 Oct 2025 · Regulation
Cannabis Industrie · №184 · 12 Feb 2021 · Medical
cyprus-mail.com · №160 · 14 Aug 2020 · Medical
MJBizDaily · №159 · 7 Aug 2020 · Regulation
№124 · 29 Nov 2019 · Regulation
№99 · 7 Jun 2019 · Regulation
In 2017, Cyprus passed a law allowing for the treatment of patients with advanced stages of cancer with medical cannabis oil. This law was expanded in 2019 to include patients suffering from chronic painful conditions associated with cancer, HIV, degenerative diseases of the motor system, rheumatism, neuropathy and glaucoma, as well as Tourette’s syndrome and Crohn’s disease.
As well as this expansion in eligible conditions, the 2019 law legalised the cultivation, manufacture, import and export of cannabis.
Despite the progress made in legalising the medical use of cannabis in Cyprus, a larger regulatory framework for patient access has not been developed. The only way a patient could access medical cannabis is under exceptional approval from the Minister of Health, upon application by a physician on behalf of the patient. Likewise, there has been no development of a medical cannabis production industry in the country.
Until there is further regulatory development, medical cannabis activity in Cyprus will remain limited.